Marinova launches graduate program to teach students about fucoidan business
The Marinova Graduate Program is a one-year program.
Fucoidan-ingredients supplier Marinova (Tasmania, Australia) has launched the Marinova Graduate Program to teach students the ins and outs of the fucoidan business. The goal is to “support the next generation of fucoidan experts,” the company’s press release states.
“As the world’s only producer of high-purity, certified-organic fucoidan with global regulatory acceptance, Marinova is committed to nurturing the next generation of fucoidan experts,” said Paul Garrott, Marinova’s CEO, in the press release. “Our exceptional leadership team will be mentoring our first graduate over the course of the next 12 months, providing experience across all facets of the company’s operations. Following successful completion of the program, graduates are offered a permanent role at Marinova in the area most suited to their skillset and interests.”
The first candidate taking part in the graduate program is Ellie Paine, a scientist with a PhD in seaweed science.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.
